Prosecution Insights
Last updated: May 29, 2026
Application No. 18/035,668

METHOD AND APPARATUS FOR MASS SPECTROMETRY

Non-Final OA §102§103
Filed
May 05, 2023
Priority
Nov 05, 2020 — provisional 63/110,199 +2 more
Examiner
MASKELL, MICHAEL P
Art Unit
2878
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Ohio State Innovation Foundation
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
924 granted / 1073 resolved
+18.1% vs TC avg
Moderate +9% lift
Without
With
+9.2%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
10 currently pending
Career history
1083
Total Applications
across all art units

Statute-Specific Performance

§101
2.5%
-37.5% vs TC avg
§103
66.5%
+26.5% vs TC avg
§102
24.8%
-15.2% vs TC avg
§112
2.6%
-37.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1073 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 4, 7, 8, 11, 16, 25, 28, 31, 38 and 63 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Badu-Tawiah, et al (U.S. Patent Application Publication 2016/0329198 A1). Regarding claim 1, Badu-Tawiah discloses an apparatus comprising: One or more sampling vessels (t-shaped cavity in Fig. 3) having an inlet and an outlet (Fig. 3), wherein the one or more sampling vessels is configured to receive a predetermined volume of an analyte sample and to form a headspace within the one or more sampling vessels (Fig. 3; paragraph 0152); wherein the inlet and the outlet are in fluid communication with the headspace (Fig. 3); and wherein the outlet is configured to allow fluid communication between the one or more sampling vessels and an analyzer (Fig. 3 – MS); One or more electrospray electrodes (Fig. 3 - ES Emitter) disposed within the one or more sampling vessels such that it is in electrical communication with at least the headspace of the one or more sampling vessel (Fig. 3; paragraph 0152); A corona electrode disposed outside of the one or more sampling vessels (Fig. 39 – corona discharge electrode) and configured under effective conditions to form a corona discharge (paragraph 0229), wherein the corona discharge is formed adjacent to the outlet of the one or more sampling vessels (paragraph 0232); Wherein each of the one or more sampling vessels comprises one of the one or more ESI electrodes (Figs. 3 and 38), Wherein the one or more ESI electrodes and the corona electrode are in electrical communication with at least one high voltage source (paragraphs 0227 and 0238); and Wherein the device is an ion source adapted for mass spectrometry (Title). Regarding claim 4, Badu-Tawiah discloses wherein the inlet of the one or more sampling vessels is configured to be in fluid communication with at least one composition comprising one or more of a reagent, an analyte, a modifier, or a combination thereof (Fig. 51). Regarding claim 7, Badu-Tawiah discloses wherein the at least one composition is in fluid communication with at least the headspace of the at one or more sampling vessels (Fig. 51). Regarding claim 8, Badu-Tawiah discloses wherein the at least one composition is in electrical communication with the one or more ESI electrodes (Fig. 51). Regarding claim 11, Badu-Tawiah discloses wherein the corona electrode is in electrical communication with one or more supplementary samples that are the same or different from the analyte sample and are configured to be at least partially vaporized and ionized by the corona discharge (for example, paragraphs 0039-0042 disclose analysis of mixtures of two analytes). Regarding claim 16, Badu-Tawiah discloses wherein the corona electrode is positioned within a vessel having an inlet and an outlet (paragraph 0238). Regarding claim 25, Badu-Tawiah discloses wherein the one or more ESI electrodes is configured to be positioned within the analyte sample when present in the one or more sampling vessels (the ESI emitter is inserted into the sampling vessel, so when the analyte sample is present in the sampling vessel, the ESI emitter witll be positioned within the analyte sample). Regarding claim 28, the voltage supplied by the at least one high voltage source can only be positive or negative; therefore the claim does not further limit its parent claim. Regarding claim 31, it is implied that the mass spectrometer in, e.g. Fig. 19A is connected to a high voltage source, because a high voltage source is necessary for a mass spectrometer to operate. Regarding claim 38, Badu-Tawiah discloses wherein the one or more ESI electrodes is configured to generate a plurality of charged droplets when the analyte sample is present, and wherein the plurality of charge droplets exit the one or more sampling vessels at the outlet (Figs. 3 and 4). Regarding claim 63, Badu-Tawiah discloses an apparatus comprising: One or more sampling vessels (t-shaped cavity in Fig. 3) having an inlet and an outlet (Fig. 3), wherein the one or more sampling vessels is configured to receive a predetermined volume of an analyte sample and to form a headspace within the one or more sampling vessels (Fig. 3; paragraph 0152); wherein the inlet and the outlet are in fluid communication with the headspace (Fig. 3); and wherein the outlet is configured to allow fluid communication between the one or more sampling vessels and an analyzer (Fig. 3 – MS); One or more non-inert (paragraph 0097) electrospray electrodes (Fig. 3 - ES Emitter) disposed within the one or more sampling vessels such that it is in electrical communication with at least the headspace of the one or more sampling vessel (Fig. 3; paragraph 0152), wherein the one or more non-inert ESI electrodes are configured to catalyze a reaction within the analyte sample (paragraph 0203); A corona electrode disposed outside of the one or more sampling vessels (Fig. 39 – corona discharge electrode) and configured under effective conditions to form a corona discharge (paragraph 0229), wherein the corona discharge is formed adjacent to the outlet of the one or more sampling vessels (paragraph 0232); Wherein each of the one or more sampling vessels comprises one of the one or more non-inert ESI electrodes (Figs. 3 and 38), Wherein the one or more ESI electrodes and the corona electrode are in electrical communication with at least one high voltage source (paragraphs 0227 and 0238); and Wherein the device is an ion source adapted for mass spectrometry (Title). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 34, 37, 40, 44-46 and 47 is/are rejected under 35 U.S.C. 103 as being unpatentable over Badu-Tawiah. Regarding claims 34 and 37, Badu-Tawiah does not specify positioning the one or more ESI electrodes about 1 to 10 mm from the corona electrode, or wherein the at least one composition is positioned about 5 mm to 10 mm from the one or more ESI electrodes and/or the corona electrode; however, Badu-Tawiah does recognize the positions of the ESI electrodes, the corona electrode, and the at least one composition as a result-effective variable, and therefore teaches changing said positions to the optimal setup for the particular experiment (paragraph 0232). Because these parameters were recognized in the prior art as result-effective variables, choosing to position the one or more ESI electrodes about 1-10 mm from the corona electrode, or the composition about 5-10 mm from the one or more ESI electrodes and/or the corona electrode, would have been obvious to one of ordinary skill in the art before the effective filing date of the invention, while conducting routine experimentation to determine the optimum or workable ranges of said variables. See In re Antonie, 559 F.2d 618 (CCPA 1977) see also MPEP 2144.05(II). Claims 40 and 46 are drawn to an apparatus comprising at least two copies of the sampling vessels described in claims 1 and 25. The mere duplication of parts has no patentable significance unless a new and unexpected result is produced. In re Harza, 274 F.2d 669 (CCPA 1960); see also MPEP 2144.04(VI)(B). Regarding claims 44 and 45, Badu-Tawiah discloses wherein the first ESI electrode is in fluid and electrical communication with the headspace of the first sampling vessel (Figs. 3 and 38). Regarding claim 47, Badu-Tawiah discloses wherein the second ESI electrode is in electrical communication with the analyte sample when present in the second sampling vessel (Figs. 3 and 38). Allowable Subject Matter Claims 14 and 64 are objected to as being dependent from a rejected claim, but would be allowable if rewritten in independent form including the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Regarding claim 14, the prior art fails to teach wherein at least one of the one or more supplementary analyte samples comprise at least one volatile, solid compound, wherein the at least one of one or more supplementary analyte samples comprising at least one solid compound positioned from the corona electrode at an effective distance that allows to at least partially vaporize and ionize the at least one solid compound with the corona discharge. Regarding claim 64, the prior art fails to teach wherein at least one high voltage source is not in communication with the mass spectrometer, as a mass spectrometer inherently needs a high voltage source in communication with it to operate. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL P MASKELL whose telephone number is (571)270-3210. The examiner can normally be reached M-F 10A-6P. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Kim can be reached at 571-272-2293. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL MASKELL/Primary Examiner, Art Unit 2881 07 February 2026
Read full office action

Prosecution Timeline

May 05, 2023
Application Filed
Feb 25, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12640357
SYSTEMS AND METHODS FOR CONTROLLING FLOW THROUGH AN OPEN PORT INTERFACE
2y 11m to grant Granted May 26, 2026
Patent 12640332
BLANKER-ENHANCED MOIRE IMAGING
2y 8m to grant Granted May 26, 2026
Patent 12633494
Stage Device, Charged Particle Beam Device, and Vacuum Device
2y 5m to grant Granted May 19, 2026
Patent 12625118
IDLE-TRIGGERED DIAGNOSTICS FOR SCIENTIFIC INSTRUMENTS
2y 8m to grant Granted May 12, 2026
Patent 12617713
SUBSTRATE, METHOD FOR PRODUCING SUBSTRATE, AND METHOD FOR PRODUCING UNIT CELL
2y 8m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
95%
With Interview (+9.2%)
2y 1m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1073 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month